Here's Billionaire Stanley Druckenmiller's Top Holding (Hint: It's Not Alphabet or Nvidia)

Billionaire investor Stanley Druckenmiller’s family office holds a $600 million (18% of the portfolio) position in genetic-testing company Natera, a stake that spotlights investor interest in faster-growing, mid-cap healthcare names versus largest mega-cap tech stocks. Natera — market cap ~ $30 billion — reported $2.3 billion revenue last year (up ~35% YoY); analysts forecast ~$2.8 billion this year and ~$3.3 billion next year and see EPS improving from a $1.58 loss to a $0.32 loss next year and a $1.43 profit in 2028. The article frames Druckenmiller’s bet as a high-conviction, higher-risk play that could attract attention to genomics and diagnostic names, while cautioning retail investors about the stock’s uncertainty and wide analyst earnings range.